Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00252_DB00755_nanopub.RAdeiQeIhoZkzcdEejem06LRJw_A21CJdpPV6uRblP-G4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00252_DB00755 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00252_DB00755 label "DDI between Phenytoin and Tretinoin - The strong CYP2C8 inducer, Phenytoin, may increase the metabolism and clearance of oral Tretinoin. Consider alternate therapy to avoid failure of Tretinoin therapy or monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Phenytoin is initiated, discontinued or dose changed. [drugbank_resource:DB00252_DB00755]" assertion.
- drugbank_resource:DB00252_DB00755 identifier "drugbank_resource:DB00252_DB00755" assertion.
- drugbank_resource:DB00252_DB00755 title "DDI between Phenytoin and Tretinoin - The strong CYP2C8 inducer, Phenytoin, may increase the metabolism and clearance of oral Tretinoin. Consider alternate therapy to avoid failure of Tretinoin therapy or monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Phenytoin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00252 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00252_DB00755 assertion.
- drugbank:DB00755 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00252_DB00755 assertion.